Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

MMF and Calcineurin Inhibitor Withdrawal in CAN

This study has been terminated.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT00204230
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2002
  Estimated Primary Completion Date: No date given
Publications: